<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with clonal myeloid disorders, especially <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), may acquire <z:e sem="disease" ids="C0002312" disease_type="Disease or Syndrome" abbrv="">alpha-thalassaemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>To estimate the prevalence of this erythrocyte phenotype, we examined brilliant cresyl blue-stained blood smears from 201 patients with neoplastic myeloid disorders and 282 controls (195 non-clonal <z:hpo ids='HP_0001903'>anaemia</z:hpo>, 62 with medical illnesses without <z:hpo ids='HP_0001903'>anaemia</z:hpo> and 25 healthy persons) </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="34" ids="35143">Haemoglobin</z:chebi> H inclusions were detected in 8/100 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (8%) and 2/81 (2.5%) patients with <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo>, but in none of the <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> patients or controls </plain></SENT>
<SENT sid="3" pm="."><plain>We conclude that the emergence of thalassaemic clones may be relatively common in the disordered marrow milieu of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>